Titre : | The effects of oxytocin on social cognition in borderline personality disorder (2018) |
Auteurs : | SERVAN A ; BRUNELIN JÉRÔME ; POULET EMMANUEL |
Type de document : | Article |
Dans : | ENCEPHALE (1 vol 44, 2018) |
Article en page(s) : | 46-51 |
Descripteurs |
[SANTEPSY] COGNITION SOCIALE [SANTEPSY] ETAT LIMITE [SANTEPSY] REVUE DE LA LITTERATURE [SANTEPSY] TROUBLE DE LA PERSONNALITE |
Mots-clés libres: | OXYTOCINE |
Résumé : | Deficits in social cognition and interpersonal difficulties are key features in borderline personality disorder. Social cognition refers to the function of perceiving and adequately dealing with social signals, leading to the establishment and maintenance of healthy and positive social relationships. Evidence suggests that oxytocin (OT) may improve social cognition and human social behavior. Recently, several studies have highlighted the beneficial effects of oxytocin in several psychiatric conditions involving social cognition deficits such as schizophrenia, autism or social phobia. However, despite growing interest, the effects of oxytocin in patients with borderline personality disorder are far from being clearly demonstrated. These data lead us to consider oxytocin as a treatment for emotion recognition deficit and hypervigilance towards social threats in borderline personality disorder. A beneficial effect of oxytocin of this nature may be obtained only in patients without deficits in trust and cooperation because of a risk of aggravating relational instability. There was no current evidence for the interest of oxytocin in enhancing affective and cognitive empathy in borderline personality disorder. Further studies are needed to evaluate the clinical interest of combining oxytocin with psychotherapeutic approaches such as dialectical behavioral therapy or mentalisation-based treatment. [Extrait du résumé] |
En ligne : | http://www.em-premium.com/article/1197850 |